
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.300 | 0.820 | 0.520 |
Shares | 99.700 | 99.700 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.267 | 18.164 |
Price to Book | 2.993 | 3.695 |
Price to Sales | 2.718 | 5.353 |
Price to Cash Flow | 13.705 | 13.633 |
Dividend Yield | 1.201 | 0.516 |
5 Years Earnings Growth | 6.316 | 19.708 |
Number of long holdings: 97
Number of short holdings: 25
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 3.55 | 107.65 | +2.28% | |
Vericel Corp Ord | US92346J1088 | 3.55 | 57.78 | +0.87% | |
Bio-Techne | US09073M1045 | 3.38 | 65.80 | +0.78% | |
Novartis | CH0012005267 | 3.32 | 96.59 | +0.44% | |
PTC Therapeutics | US69366J2006 | 3.31 | 50.43 | +1.98% | |
Alnylam | US02043Q1076 | 3.25 | 250.51 | +0.20% | |
Bristol-Myers Squibb | US1101221083 | 3.15 | 54.98 | +1.01% | |
Lonza Group | CH0013841017 | 3.12 | 580.00 | -0.92% | |
Vertex | US92532F1003 | 3.01 | 471.76 | +2.09% | |
Arcellx Inc | - | 3.00 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund A acc USD he | 18.03B | 1.97 | 2.69 | 3.91 | ||
JPI Global Income Fund A div USD he | 18.03B | 1.98 | 2.70 | 3.92 | ||
JPI Global Income Fund A mth USD he | 18.03B | 1.98 | 2.67 | 3.89 | ||
JPI Global Income Fund C acc USD he | 18.03B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund C mth USD he | 18.03B | 2.03 | 3.37 | 4.59 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review